Dan-Qi prescription ameliorates insulin resistance through overall corrective regulation of glucose and fat metabolism

Journal of Ethnopharmacology

Volumn 172, Issue , 2015, Pages 70-79

  Xie, Zhishen ^a   Loi Truong, Thanh ^a   Zhang, Pei ^a   Xu, Fengguo ^a   Xu, Xiaojun ^a   Li, Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Insulin resistant; Obesity; Panax notoginseng; Salvia miltiorrhiza Bung

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; CHOLESTEROL; FATTY ACID SYNTHASE; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCOGEN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PANAX NOTOGINSENG EXTRACT; PYRUVATE KINASE; ROSIGLITAZONE; SALVIA MILTIORRHIZA EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; HERBACEOUS AGENT; PLANT EXTRACT; SANQI;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET INDUCED OBESITY; DRUG EFFICACY; DRUG POTENTIATION; FATTY LIVER; FRUIT FLY MODEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PANAX NOTOGINSENG; PRESCRIPTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALVIA MILTIORRHIZA; ANIMAL; CHEMISTRY; COMBINATION DRUG THERAPY; DISEASE MODEL; DROSOPHILA; DRUG EFFECTS; EATING; GENE EXPRESSION; LIVER; METABOLISM; PLANT ROOT; RHIZOME;

MUS; PANAX NOTOGINSENG; SALVIA MILTIORRHIZA;

ANIMALS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DROSOPHILA; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; EATING; GENE EXPRESSION; GLUCOSE; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MICE; PLANT EXTRACTS; PLANT ROOTS; RHIZOME; SALVIA MILTIORRHIZA;

EID: 84935507162     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.05.041     Document Type: Article

References (41)

1. L. Agius Glucokinase and molecular aspects of liver glycogen metabolism Biochem. J. 414 2008 1 18
2. J.M. Chehade, M. Gladysz, and A.D. Mooradian Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management Drugs 73 2013 327 339
3. A.H. Chen, and C.H. Tseng The role of triglyceride in cardiovascular disease in Asian patients with type 2 diabetes - a systematic review Rev. Diabet. Stud. RDS 10 2013 101 109
4. J. Chen, J. Deng, Y. Zhang, J. Yang, Y. He, W. Fu, P. Xing, and H. Wan Lipid-lowering effects of Danhong injection on hyperlipidemia rats J. Ethnopharmacol. 154 2014 437 442
5. L. Chen, D.J. Magliano, and P.Z. Zimmet The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nature reviews Endocrinology 8 2012 228 236
6. T.O. Cheng Cardiovascular effects of Danshen Int. J. Cardiol. 121 2007 9 22
7. Y.F. Chen, S.W. Wang, Z.J. Luo, and G.N. Luan Compatibility of Salvia miltiorrhiza with Panax notoginseng and Rhizome Chuanxiong: effect of different extraction technologies on content of TanshinoneII A Prog. Mod. Biomed. 11 2011 127 130
8. X. Dong, S. Park, X. Lin, K. Copps, X. Yi, and M.F. White Irs1 and Irs2 signaling I s essential for hepatic glucose homeostasis and systemic growth J. Clin. Invest. 116 2006 101 114
9. N.A. Elshourbagy, H.V. Meyers, and S.S. Abdel-Meguid Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemia. International Journal of the Kuwait University, Health Science Centre Med. Princ. Pract. 23 2014 99 111
10. S.M. Grundy, I.J. Benjamin, G.L. Burke, A. Chait, R.H. Eckel, B.V. Howard, W. Mitch, S.C. Smith Jr., and J.R. Sowers Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation 100 1999 1134 1146
11. W. Ji, and B.Q. Gong Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats J. Ethnopharmacol. 119 2008 291 298
12. X.Y. Ji, B.K. Tan, and Y.Z. Zhu Salvia miltiorrhiza and ischemic diseases Acta Pharmacol. Sin. 21 2000 1089 1094
13. N.K. Kapur, D. Ashen, and R.S. Blumenthal High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease Vascu. Health Risk Manage. 4 2008 39 57
14. J. Liu, Y. Wang, L. Qiu, Y. Yu, and C. Wang Saponins of Panax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases Exp. Opin. Invest. Drugs 23 2014 523 539
15. W. Long, S.C. Zhang, L. Wen, L. Mu, F. Yang, and G. Chen In vivo distribution and pharmacokinetics of multiple active components from Danshen and Sanqi and their combination via inner ear administration J. Ethnopharmacol. 2014
16. S. Maru, G.G. Koch, M. Stender, D. Clark, L. Gibowski, H. Petri, A.D. White, and R.J. Simpson Jr. Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting Diabetes Care 28 2005 20 26
17. K. McTigue, J.C. Larson, A. Valoski, G. Burke, J. Kotchen, C.E. Lewis, M.L. Stefanick, L. Van Horn, and L. Kuller Mortality and cardiac and vascular outcomes in extremely obese women JAMA 296 2006 79 86
18. L.P. Musselman, J.L. Fink, K. Narzinski, P.V. Ramachandran, S.S. Hathiramani, R.L. Cagan, and T.J. Baranski A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila Dis. Models Mech. 4 2011 842 849
19. C.F. Ng, C.M. Koon, D.W. Cheung, M.Y. Lam, P.C. Leung, C.B. Lau, and K.P. Fung The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation J. Ethnopharmacol. 137 2011 1366 1372
20. T.B. Ng Pharmacological activity of sanchi ginseng (Panax notoginseng) J. Pharm. Pharmacol. 58 2006 1007 1019
21. S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N. Engl. J. Med. 356 471 2007 2457 2462
22. C. Pan, Y. Huo, X. An, G. Singh, M. Chen, Z. Yang, J. Pu, and J. Li Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation Vasc. Pharmacol. 56 15 2012 0 158
23. U.B. Pandey, and C.D. Nichols Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery Pharmacol. Rev. 63 2011 411 436
24. M.Y. Pasco, and P. Leopold High sugar-induced insulin resistance in Drosophila relies on the lipocalin Neural Lazarillo PLoS One 7 2012 e36583
25. Z. Reiner Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in stat in-treated patients: a clinical update Nutr. Metab. Cardiovasc. Dis.: NMCD 23 2013 799 807
26. S.M. Reilly, S.H. Chiang, S.J. Decker, L. Chang, M. Uhm, M.J. Larsen, J.R. Rubin, J. Mowers, N.M. White, I. Hochberg, M. Downes, R.T. Yu, C. Liddle, R.M. Evans, D. Oh, P. Li, J.M. Olefsky, and A.R. Saltiel An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice Nat. Med. 19 2013 313 321
27. F. Shirazi, D. Farmakiotis, Y. Yan, N. Albert, D. Kim-Anh, and D.P. Kontoyiannis Diet modification and metformin have a beneficial effect in a fly model of obesity and mu cormycosis PLoS One 9 2014 e108635
28. S. Smyth, and A. Heron Diabetes and obesity: the twin epidemics Nat. Med. 12 2006 75 80
29. B. Sung, H.S. Chung, M. Kim, Y.J. Kang, D.H. Kim, S.Y. Hwang, M.J. Kim, C.M. Kim, H.Y. Chung, and N.D. Kim Cytotoxic effects of solvent-extracted active components of Bunge on human cancer cell lines Exp. Ther. Med. 9 2015 1421 1428
30. R.E. Soccio, E.R. Chen, and M.A. Lazar Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes Cell Metab. 20 2014 573 591
31. J.J. Tang, J.G. Li, W. Qi, W.W. Qiu, P.S. Li, B.L. Li, and B.L. Song Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques Cell Metab. 13 2011 44 56
32. J.L. Unick, D. Beavers, J.M. Jakicic, A.E. Kitabchi, W.C. Knowler, T.A. Wadden, and R.R. Wing Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look A HEAD trial Diabetes Care 34 2011 2152 2157
33. D. Wing-Shing Cheung, C.M. Koon, C.F. Ng, P.C. Leung, K.P. Fung, S. Kar-Sing Poon, and C. Bik-San Lau The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibit atherogenic events: a study of the combination effects of the 2-herb formula J. Ethnopharmacol. 143 2012 859 866
34. W. Xia, C. Sun, Y. Zhao, and L. Wu Hypolipidemic and antioxidant activities of sanchi (Radix notoginseng) in rats fed with a high fat diet. International Journal of Phytotherapy and Phytopharmacology. Phytomedicine 18 2011 516 520
35. J. Xu, S. Zeng, X. Chen, and H. Qu Isolation and identification of degradation products of salvianolic acid A by NMR and LC-MS Fitoterapia 82 2011 260 266
36. X. Xu, P. Gopalacharyulu, T. Seppanen-Laakso, A.L. Ruskeepaa, C.C. Aye, B.P. Carson, S. Mora, M. Oresic, and A.A. Teleman Insulin signaling regulates fatty acid catabolim at the level of CoA activation PLoS Genet. 8 2012 e1002478
37. R. Yang, L. Chang, B.Y. Guo, Y.W. Wang, Y.L. Wang, X. Jin, S.Y. Liu, and Y.J. Li Compound danshen dripping pill pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention Evidence Based Complement. Altern. Med.: eCAM 2014 2014 256268
38. X. Yang, X. Xiong, H. Wang, and J. Wang Protective effects of Panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies Evidence Based Complement. Altern. Med.: eCAM 2014 2014 204840
39. Y. Zhang, L.F. Han, K.J. Sakah, Z.Z. Wu, L.L. Liu, K. Agyemang, X.M. Gao, and T. Wang Bioactive protopanaxatriol type saponins isolated from the roots of Panax notoginseng (Burk.) F. H. Chen Molecules 18 2013 10352 10366
40. L.N. Zhou, X. Zhang, W.Z. Xu, X.N. Ma, Z. Jia, Y.M. Zheng, and S. You Studies on the stability of salvianolic acid B as potential drug material Phytochem. Anal.: PCA 22 2011 378 384
41. L. Zhou, Z. Zuo, and M.S. Chow Danshen: an overview of its chemistry, pharmacology pharmacokinetics, and clinical use Br. J. Clin. Pharmacol. 45 2005 1345 1359